×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

HilleVax Inc. (HLVX) NASDAQ

$15.82 0.20 (1.25%)

Market Cap: $776.33M

As of 03/28/24 10:52 AM EDT. Market open.

(HLVX)

HilleVax Inc. (HLVX)
NASDAQ

$15.82
0.20 (1.25%)

Market Cap: $776.33M

As of 03/28/24 10:52 AM EDT. Market open.

Add to Portfolio

hillevax is a biopharmaceutical company focused on the development and commercialization of novel vaccines. our initial program, hil-214, is a virus-like particle (vlp) based vaccine candidate in development for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus ... read more

hillevax is a biopharmaceutical company focused on the development and commercialization of novel vaccines. our initial program, hil-214, is a virus-like particle (vlp) based vaccine candidate in development for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Full Time Employees
52
URL
Address
.
PRICE CHART FOR HILLEVAX INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$15.91
Previous Close
$15.62
Days Range
$15.53 - $16.23
52 week range
$9.94 - $20.22
Volume
7,316
Avg. Volume (30 days)
116,445
Market Cap
$776.33M
Dividend Yield
-
P/E
-
Shares Outstanding
49,700,828
Open
$15.91
Previous Close
$15.62
Days Range
$15.53 - $16.23
52 week range
$9.94 - $20.22
Volume
7,316
Avg. Volume (30 days)
116,445
Market Cap
$776.33M
Dividend Yield
-
P/E
-
Shares Outstanding
49,700,828
FINANCIAL STATEMENTS FOR HILLEVAX INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR HILLEVAX INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Kohli AdityaDirectorMar 20, 2024 Sale$164221.006,000985,326,000807,776Mar 20, 2024, 06:27 PM
Kohli AdityaDirectorMar 19, 2024 Sale$17.426,000104,492813,776Mar 20, 2024, 06:27 PM
Kohli AdityaDirectorMar 18, 2024 Sale$17.666,000105,937819,776Mar 20, 2024, 06:27 PM
Kohli AdityaDirectorMar 08, 2024 Sale$18.666,000111,959825,776Mar 08, 2024, 06:38 PM
Kohli AdityaDirectorMar 07, 2024 Sale$18.376,000110,213831,776Mar 08, 2024, 06:38 PM
Kohli AdityaDirectorMar 06, 2024 Sale$18.956,000113,701837,776Mar 08, 2024, 06:38 PM
Kohli AdityaDirectorFeb 22, 2024 Sale$15.056,00090,312843,776Feb 22, 2024, 05:20 PM
Kohli AdityaDirectorFeb 21, 2024 Sale$14.926,00089,495849,776Feb 22, 2024, 05:20 PM
Kohli AdityaDirectorFeb 20, 2024 Sale$14.886,00089,272855,776Feb 22, 2024, 05:20 PM
Kohli AdityaDirectorFeb 12, 2024 Sale$15.326,00091,921861,776Feb 14, 2024, 04:22 PM
Kohli AdityaDirectorFeb 08, 2024 Sale$14.938,866132,383812,878Feb 12, 2024, 08:06 PM
Maltbie ShaneChief Financial OfficerFeb 08, 2024 Sale$14.933,57653,39540,656Feb 12, 2024, 07:51 PM
HERSHBERG ROBERTSee RemarksFeb 08, 2024 Sale$14.9311,597173,161953,831Feb 12, 2024, 07:47 PM
Borkowski AstridChief Medical OfficerFeb 08, 2024 Sale$14.933,93358,726161,260Feb 12, 2024, 07:35 PM
Borkowski AstridChief Medical OfficerDec 15, 2023 Sale$15.5010,000155,000165,193Dec 18, 2023, 05:34 PM
Borkowski AstridChief Medical OfficerDec 01, 2023 Sale$14.2010,000142,000185,193Dec 05, 2023, 04:52 PM
Borkowski AstridChief Medical OfficerDec 04, 2023 Sale$14.5010,000145,000175,193Dec 05, 2023, 04:52 PM
Borkowski AstridChief Medical OfficerNov 17, 2023 Sale$14.0010,000140,000195,193Nov 20, 2023, 04:53 PM
Borkowski AstridChief Medical OfficerNov 08, 2023 Sale$13.005,00065,000205,193Nov 13, 2023, 05:25 PM
Borkowski AstridChief Medical OfficerJun 21, 2023 Option Exercise$16.1110,000161,100210,193Jun 23, 2023, 10:09 AM
Frazier Life Sciences X, L.P.10% OwnerMay 03, 2022 Option Exercise$13.602,736,23437,212,7836,770,631May 03, 2022, 04:23 PM
Frazier Life Sciences X, L.P.10% OwnerMay 03, 2022 Buy$17.001,764,70630,000,0028,535,337May 03, 2022, 04:23 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Kohli AdityaDirector03/20/2024985,326,000
Kohli AdityaDirector03/19/2024104,492
Kohli AdityaDirector03/18/2024105,937
Kohli AdityaDirector03/08/2024111,959
Kohli AdityaDirector03/07/2024110,213
Kohli AdityaDirector03/06/2024113,701
Kohli AdityaDirector02/22/202490,312
Kohli AdityaDirector02/21/202489,495
Kohli AdityaDirector02/20/202489,272
Kohli AdityaDirector02/12/202491,921
Kohli AdityaDirector02/08/2024132,383
Maltbie ShaneChief Financial Officer02/08/202453,395
HERSHBERG ROBERTSee Remarks02/08/2024173,161
Borkowski AstridChief Medical Officer02/08/202458,726
Borkowski AstridChief Medical Officer12/15/2023155,000
Borkowski AstridChief Medical Officer12/01/2023142,000
Borkowski AstridChief Medical Officer12/04/2023145,000
Borkowski AstridChief Medical Officer11/17/2023140,000
Borkowski AstridChief Medical Officer11/08/202365,000
Borkowski AstridChief Medical Officer06/21/2023161,100
Frazier Life Sciences X, L.P.10% Owner05/03/202237,212,783
Frazier Life Sciences X, L.P.10% Owner05/03/202230,000,002
Load More Insider Transactions
FUNDS WITH A POSITION IN HILLEVAX INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)4,004,2311.19%No changeOther
BLACKROCK INC.1,775,9370.00073%37.93%Other
GEODE CAPITAL MANAGEMENT, LLC591,1450.00099%41.32%Other
ADAGE CAPITAL PARTNERS GP, L.L.C.198,4390.00659%12.42%Other
UBS OCONNOR LLC61,0590.07%-46.66%Value
ALPS ADVISORS INC28,9140.00323%ExitedOther
TUDOR INVESTMENT CORP ET AL17,7240.00229%No changeEvent Driven, Other
CHANGE IN SHARES OUTSTANDING FOR HILLEVAX INC
STOCK BUYBACKS FOR HILLEVAX INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
06/30/2023
25.51%
2Q
12/31/2023
03/31/2023
26.17%
3Q
12/31/2023
09/30/2022
27.63%
5Q
12/31/2023
06/30/2022
79.67%
6Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2023
25.51%
2Q
03/31/2023
26.17%
3Q
09/30/2022
27.63%
5Q
06/30/2022
79.67%
6Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR HILLEVAX INC
LOADING...